By: Clare Logan
CHRNA4 Gene and Epilepsy
What is the CHRNA4 Gene?
The CHRNA4 gene provides instructions for making one part of a brain receptor called the alpha-4 (α4) subunit of the nicotinic acetylcholine receptor. This receptor helps brain cells communicate with each other using a chemical messenger called acetylcholine. These receptors are especially important in areas of the brain that control attention, movement, and the sleep–wake cycle. When the CHRNA4 gene is working normally, it helps keep brain signaling balanced. The receptor turns on briefly when acetylcholine binds to it, allowing charged particles to enter the neuron and pass along signals in a controlled way. The α4 subunit usually pairs with another subunit, called β2, to form one of the most common receptor types in the brain.
However, certain changes, also known as variants, in the CHRNA4 gene can alter how this receptor works. Many of these variants make the receptor more sensitive than usual, meaning it can become overactive even with normal levels of acetylcholine. This increased activity can make groups of brain cells more excitable than they should be, which can lead to seizures. Variants in CHRNA4 are most often linked to a genetic form of epilepsy called autosomal dominant sleep-related hypermotor epilepsy (ADSHE). This condition is inherited in an autosomal dominant pattern, meaning only one altered copy of the gene is needed to increase the chance of developing epilepsy.
CHRNA4-Related Epilepsy
Epilepsy related to CHRNA4 usually involves seizures that happen during sleep. These seizures often occur during the deeper stages of sleep and can cause sudden, sometimes intense movements. A person might sit up abruptly, thrash, kick, or make repeated movements. Because these episodes happen at night, they are sometimes mistaken for sleep disorders like night terrors or sleepwalking.
Seizures often begin in childhood or the teenage years, but the exact age can vary by individual. Some people may have only occasional episodes, while others may have several in one night. During these events, awareness may be partly preserved, and some individuals remember what happened. These seizures are thought to come from the frontal lobes, areas of the brain highly involved in movement and behavior. Changes in the CHRNA4 receptor make certain brain circuits more easily activated, especially during sleep when brain activity naturally shifts. This can trigger the sudden bursts of activity that lead to seizures.
Research and Treatment
Currently, there is no cure for CHRNA4-related epilepsy, but many people are able to control their seizures with medication. Drugs that stabilize electrical activity in the brain are commonly used, and carbamazepine is often effective for this type of epilepsy, although responses can differ from person to person.
Researchers have learned that CHRNA4-related epilepsy is caused by subtle changes in how brain receptors function. Even small increases in receptor activity can disrupt the balance of brain signaling. Understanding this has helped explain why seizures tend to occur during sleep and why certain medications work better than others.
Overall, many individuals with CHRNA4 variants have good long-term outcomes, especially when seizures are well controlled. Most people have normal brain scans and typical development, although some may experience mild challenges with sleep, attention, or mood. Ongoing research is focused on better understanding how specific genetic changes affect the receptor and on developing treatments that more directly target these receptors. Improved genetic testing has also made it easier to diagnose this condition and distinguish it from other sleep-related disorders.
Resources
Hirose S, Iwata H, Akiyoshi H, Kobayashi K, Ito M, Wada K, Kaneko S, Mitsudome A. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology. 1999 Nov 10;53(8):1749-53. doi: 10.1212/wnl.53.8.1749. PMID: 10563623.
Kurahashi H, Hirose S. Autosomal Dominant Sleep-Related Hypermotor (Hyperkinetic) Epilepsy. 2002 May 16 [Updated 2023 Mar 23]. In: Adam MP, Bick S, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1169/
Scheffer IE, Bhatia KP, Lopes-Cendes I, Fish DR, Marsden CD, Andermann E, Andermann F, Desbiens R, Keene D, Cendes F, et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain. 1995 Feb;118 ( Pt 1):61-73. doi: 10.1093/brain/118.1.61. PMID: 7895015.
Steinlein, O. K., Mulley, J. C., Propping, P., Wallace, R. H., Phillips, H. A., Sutherland, G. R., Scheffer, I. E., & Berkovic, S. F. (1995). A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genetics, 11(2), 201–203. https://doi.org/10.1038/ng1095-201
Steinlein OK. Genetic mechanisms that underlie epilepsy. Nat Rev Neurosci. 2004 May;5(5):400-8. doi: 10.1038/nrn1388. PMID: 15100722.
